# Combined Mirtazapine and SSRI Treatment of PTSD: A Placebo-Controlled Trial

> **NCT01178671** · PHASE4 · COMPLETED · sponsor: **Research Foundation for Mental Hygiene, Inc.** · enrollment: 38 (actual)

## Conditions studied

- Posttraumatic Stress Disorder

## Interventions

- **DRUG:** Mirtazapine
- **DRUG:** Sertraline
- **OTHER:** Sugar pill

## Key facts

- **NCT ID:** NCT01178671
- **Lead sponsor:** Research Foundation for Mental Hygiene, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2014-05
- **Final completion:** 2014-06
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2016-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01178671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01178671, "Combined Mirtazapine and SSRI Treatment of PTSD: A Placebo-Controlled Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01178671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*